SLCTR/2022/020尚未招募未知
Efficacy of bupropion in the Pharmacological Management of Betel Quid Addiction.
Centre for Research in Oral Cancer0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Adults above 18 years of age.
- •2. Both male and female.
- •3. Regular Betel Quid user – at least 1 quid per day or 7 quids per week during the last 6 months.
- •4. Betel quid users with at least one of the 2 ingredients in their quid; areca-nut and/or chewing tobacco.
- •5. Betel Quid dependent users with a Betel Quid Dependence Score (BQDS) of more than 4.
- •6. Able to understand the provisions of the protocol with which subject must comply and be willing to sign an informed consent.
- •7. Betel Quid users who are willing to quit by answering as ‘yes’ to the question ‘ Are you willing to quit your habit during the treatment phase of this trial?’ in the screening questionnaire.
排除标准
- •1.Patients with a self-reported history of seizures within the last 05 years.
- •2.Patients with diagnosed depression or suicidal behavior within last 01 year.
- •3.Patients with hepatic diseases such as cirrhosis and end stage liver failure.
- •4.Pregnant or nursing mothers.
- •5.Participants with unstable angina or a myocardial infarction within 3 months of enrollment.
- •6.Participants with tobacco smoking habits.
- •7.Patients already using an anti-psychotic or anti-depressant for other medical reasons.
- •8.Already undergone a pharmacological nicotine dependence treatment program within the past 03 months.
- •9.With a history of severe head trauma with loss of consciousness
- •10.With a history of an eating disorder such as anorexia nervosa or bulimia
- •11.Patients taking routine medication as listed below.
- •most antidepressants (SSRIs, many tricyclics),
- •beta-blockers
- •antiarrhythmics
- •antipsychotics antidepressants (e.g., nortriptyline, imipramine, desipramine, paroxetine, fluoxetine, sertraline)
- •antipsychotics (e.g., haloperidol, risperidone, thioridazine)
- •beta-blockers (e.g., metoprolol)
- •Type 1C antiarrhythmics (e.g., propafenone, flecainide
- •* MAO Inhibitors (phenelzine)
- •* Levodopa
- •* Amantadine
研究者
相似试验
尚未招募
3 期
Effect of Bupropion versus placebo on the management of fatigue caused by multiple sclerosisMultiple sclerosisMultiple sclerosis.IRCT20120215009014N465Hamedan University of Medical Sciences46
招募中
2 期
Comparison of bupropion, fluoxetine, and methylphenidate in cancer-related fatigueIRCT20180623040193N3Shahre-kord University of Medical Sciences60
已完成
2 期
Comparison of effect of bupropion and venlafaxine in children with hyperactivityAttention deficit hyperactivity disorder.Attention deficit: disorder with hyperactivity, hyperactivity disorder and syndrome with hyperactivityF90.0, F90IRCT201306189175N5Vice chancellor for research, Mashhad University of Medical Sciences40
已完成
2 期
Efficacy of Buprenorphine in the Methamphetamine DependencyMethamphetamine dependency.Mental and behavioural disorders due to use of other stimulants, including caffeineIRCT2013112315499N1Vice chancellor for research, Tehran University of Medical Sciences21
进行中（未招募）
不适用
Clinical evaluation study: Bupropion versus Psychodynamic mental training according to Dr. Grohs for smoke withdrawal(Klinische Evaluierungsstudie: Bupropion versus Psychodynamisches Mentaltraining nach Dr. Grohs zur Raucherentwöhnung - Bupropion vs. PDM zur RaucherentwöhnungEUCTR2005-006189-32-ATSteiermärkische Gebietskrankenkasse